An <i>In Silico</i> Pharmacophore-driven Virtual Screening and Molecular Docking for Identifying Potential AKT Inhibitors of Natural Origin

Background: Breast cancer accounts for 6.9% of cancer-related fatalities and 11.7% of new cases globally, making it the most often diagnosed cancer. Primarily seen in breast cancer is hyperactivation of the AKT/PI3K/mTOR pathway. Key signalling protein in this mechanism, AKT is essential for cell survival, proliferation, therapeutic resistance, and cancer progression. Aim: This study aims to identify potent phytochemical derivatives from the ZINC Natural derivatives database through virtual screening using known standard drugs. It integrates the pharmacophore features of selective compounds to screen a natural compound library, identifying potential anticancer agents. Methods: A ligand-based pharmacophore model was initially developed and validated by using known potent phytoconstituents such as Berberine, Lycorine, Noscapine, and Haemanthidine (IC50 < 20 ?M). A validated model having four key features was used to screen the ZINC Natural derivatives database and identified 612 hits with essential AKT inhibitory features and further subjected to molecular docking studies. ADMET analysis and pharmacokinetic properties were assessed for the top lead compounds. Results: Molecular docking studies found ZINC 20412215 was the most potent AKT inhibitor, with a docking score of -8.36 kcal/mol, than the standard drug Capivasertib (-8.07 kcal/mol). It exhibits better aqueous solubility, high gastrointestinal absorption, and a lower likelihood of CYP2D6-mediated metabolic interference compared to Capivasertib. It is non-hepatotoxic and cytotoxic, with potential metabolic interactions of the molecules. Conclusion: These findings revealed that the compound ZINC 20412215 is a potential lead for AKT-targeted breast cancer therapy. Further experimental validation is required to advance its development as an effective anticancer agent. Major Findings: The study identified novel AKT inhibitors from the ZINC natural compound library using pharmacophore modeling, docking, and ADMET ana

View article page

Download PDF